Cyclica

Cyclica was named one of Business Insider’s Top Biotech Startups set to take off in the next 12 months.

We’re incredibly humbled and proud of our team after just learning that Business Insider Insider has named Cyclica to their top list of biotech start-up companies set to take off in the next 12 months.

The prestigious nomination came from Chris Garabedian, who indicates that: “Cyclica could end up being best-in-class in this space, even though others have gotten a lot more attention and attracted a lot more capital.”

Thanks, Chris and to all who have supported Cyclica throughout our journey as we continue to embrace the complexity of the disease.